The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Clinical trial NCT04981145 · RECRUITING
Trial details
- NCT number
- NCT04981145
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2024-12-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.